343 related articles for article (PubMed ID: 29789271)
1. Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity.
Agrawal A; Parlee S; Perez-Tilve D; Li P; Pan J; Mroz PA; Kruse Hansen AM; Andersen B; Finan B; Kharitonenkov A; DiMarchi RD
Mol Metab; 2018 Jul; 13():45-55. PubMed ID: 29789271
[TBL] [Abstract][Full Text] [Related]
2. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.
Yang C; Jin C; Li X; Wang F; McKeehan WL; Luo Y
PLoS One; 2012; 7(3):e33870. PubMed ID: 22442730
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M
J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664
[TBL] [Abstract][Full Text] [Related]
4. Identification of a crucial amino acid responsible for the loss of specifying FGFR1-KLB affinity of the iodinated FGF21.
Luo W; Lin XM; Wang TX; Cai JL; Zeng XF; Zhu CR; Li RZ; Wang H; Wu XP
J Cell Physiol; 2019 Mar; 234(3):2500-2510. PubMed ID: 30317562
[TBL] [Abstract][Full Text] [Related]
5. Optimization of Peptide Inhibitors of β-Klotho as Antagonists of Fibroblast Growth Factors 19 and 21.
Pan J; Parlee SD; Brunel FM; Li P; Lu W; Perez-Tilve D; Liu F; Finan B; Kharitonenkov A; DiMarchi RD
ACS Pharmacol Transl Sci; 2020 Oct; 3(5):978-986. PubMed ID: 33073195
[TBL] [Abstract][Full Text] [Related]
6. Fundamentals of FGF19 & FGF21 action in vitro and in vivo.
Adams AC; Coskun T; Rovira AR; Schneider MA; Raches DW; Micanovic R; Bina HA; Dunbar JD; Kharitonenkov A
PLoS One; 2012; 7(5):e38438. PubMed ID: 22675463
[TBL] [Abstract][Full Text] [Related]
7. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho.
Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y
J Mol Biol; 2012 Apr; 418(1-2):82-9. PubMed ID: 22370560
[TBL] [Abstract][Full Text] [Related]
8. Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho.
Aaldijk AS; Verzijl CRC; Jonker JW; Struik D
Front Endocrinol (Lausanne); 2023; 14():1150222. PubMed ID: 37260446
[TBL] [Abstract][Full Text] [Related]
9. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice.
Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14379-84. PubMed ID: 19706524
[TBL] [Abstract][Full Text] [Related]
10. The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue.
Adams AC; Yang C; Coskun T; Cheng CC; Gimeno RE; Luo Y; Kharitonenkov A
Mol Metab; 2012; 2(1):31-7. PubMed ID: 24024127
[TBL] [Abstract][Full Text] [Related]
11. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors.
Wu X; Lemon B; Li X; Gupte J; Weiszmann J; Stevens J; Hawkins N; Shen W; Lindberg R; Chen JL; Tian H; Li Y
J Biol Chem; 2008 Nov; 283(48):33304-9. PubMed ID: 18829467
[TBL] [Abstract][Full Text] [Related]
12. Dynamics and Distribution of Klothoβ (KLB) and fibroblast growth factor receptor-1 (FGFR1) in living cells reveal the fibroblast growth factor-21 (FGF21)-induced receptor complex.
Ming AY; Yoo E; Vorontsov EN; Altamentova SM; Kilkenny DM; Rocheleau JV
J Biol Chem; 2012 Jun; 287(24):19997-20006. PubMed ID: 22523080
[TBL] [Abstract][Full Text] [Related]
13. The central fibroblast growth factor receptor/beta klotho system: Comprehensive mapping in Mus musculus and comparisons to nonhuman primate and human samples using an automated in situ hybridization platform.
Hultman K; Scarlett JM; Baquero AF; Cornea A; Zhang Y; Salinas CBG; Brown J; Morton GJ; Whalen EJ; Grove KL; Koegler FH; Schwartz MW; Mercer AJ
J Comp Neurol; 2019 Aug; 527(12):2069-2085. PubMed ID: 30809795
[TBL] [Abstract][Full Text] [Related]
14. Liver-specific activities of FGF19 require Klotho beta.
Lin BC; Wang M; Blackmore C; Desnoyers LR
J Biol Chem; 2007 Sep; 282(37):27277-27284. PubMed ID: 17627937
[TBL] [Abstract][Full Text] [Related]
15. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
[TBL] [Abstract][Full Text] [Related]
16. Nutritional regulation of fibroblast growth factor 21: from macronutrients to bioactive dietary compounds.
Pérez-Martí A; Sandoval V; Marrero PF; Haro D; Relat J
Horm Mol Biol Clin Investig; 2016 Sep; 30(1):. PubMed ID: 27583468
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 21, fibroblast growth factor receptor 1, and β-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice.
Brooks NE; Hjortebjerg R; Henry BE; List EO; Kopchick JJ; Berryman DE
Growth Horm IGF Res; 2016; 30-31():22-30. PubMed ID: 27585733
[TBL] [Abstract][Full Text] [Related]
18. Different roles of N- and C- termini in the functional activity of FGF21.
Micanovic R; Raches DW; Dunbar JD; Driver DA; Bina HA; Dickinson CD; Kharitonenkov A
J Cell Physiol; 2009 May; 219(2):227-34. PubMed ID: 19117008
[TBL] [Abstract][Full Text] [Related]
19. The FGF21 Receptor Signaling Complex: Klothoβ, FGFR1c, and Other Regulatory Interactions.
Kilkenny DM; Rocheleau JV
Vitam Horm; 2016; 101():17-58. PubMed ID: 27125737
[TBL] [Abstract][Full Text] [Related]
20. Co-receptor requirements for fibroblast growth factor-19 signaling.
Wu X; Ge H; Gupte J; Weiszmann J; Shimamoto G; Stevens J; Hawkins N; Lemon B; Shen W; Xu J; Veniant MM; Li YS; Lindberg R; Chen JL; Tian H; Li Y
J Biol Chem; 2007 Oct; 282(40):29069-72. PubMed ID: 17711860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
